April 10, 2009 (Boston, Massachusetts) — Smoking has become the latest factor shown to affect responsiveness to clopidogrel (Plavix, Bristol-Myers Squibb/Sanofi-Aventis), with a new post hoc analysis ...

The UK Center of Excellence in Regulatory Science and Innovation in Pharmacogenomics (UK CERSI-PGx), led by the University of ...

Antiplatelet therapy with the ADP P2Y12 receptor antagonist clopidogrel is recommended by current clinical practice guidelines to prevent atherothrombotic events in patients with coronary artery ...

The antiplatelet drug clopidogrel helps prevent stent-associated thrombosis, but the antiplatelet effects are quite variable and the clinical consequences can be serious. New findings show that the ...

New data have added more concerns about using morphine and clopidogrel together in patients presenting with non-ST-segment elevation ACS (NSTEACS). Previous studies have shown that morphine can reduce ...

Individuals who smoke and are treated with clopidogrel have significantly lower rates of persistent platelet reactivity when compared to those who do not smoke, according to an analysis of the ...

Clopidogrel is a generic prescription medication. It is FDA-approved to help prevent cardiovascular events such as heart attack and stroke in certain adults. Specifically, clopidogrel is approved to ...

A model that combines 3 gene variants involved in clopidogrel metabolism and platelet receptor function with 2 clinical factors—clopidogrel loading dose and use of proton pump inhibitors (PPI)—can ...

A newly approved drug thins the blood faster, more consistently, and more powerfully than the standard drug, which can fail to prevent deadly blood clots in patients after they undergo a common ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Clopidogrel (Plavix) is an anti-platelet agent, ...